Bayer HealthCare Joins Structural Genomics Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – Bayer today said that its Bayer HealthCare business has joined the non-profit Structural Genomics Consortium.

Bayer will provide funding to the consortium to accelerate drug research in the areas of protein science and epigenetics. In addition, it will collaborate with the consortium on research projects to identify small molecules that can interfere with protein activity involved in epigenetic control. Bayer also said that ti will provide a subset of its compound library to the SGC for screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.